Clinical Trials Directory

Trials / Completed

CompletedNCT00793806

Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The common causes of mortality are late stages of chronic kidney disease, cardiovascular disease and infections, are associated with abnormalities of the immune system, an underlying state of chronic inflammation and oxidative stress. These processes have not been carefully described in the chronic kidney disease population. The researcher can use Diffuse Optical Spectroscopy to determine the immune system in individuals with chronic kidney disease and describe the association with chronic inflammation and oxidative stress in that population.

Detailed description

The Diffuse Optical Spectroscopy can measure the absolute concentrations of reduced and oxygenated hemoglobins,cardiac output, mean arterial pressure, blood loss,blood hemoglobin concentration, water and lipid concentrations of the tissue. The researchers can use Diffuse Optical Spectroscopy to monitor volume changes during the hemodialysis treatment and to correlate the changes in volume and blood pressure with the measures of oxidative stress and inflammation used in this study. The researchers can use Diffuse Optical Spectroscopy data to compare to laboratory parameters routinely measured to clinical parameters such as cause of chronic kidney disease, blood pressure and dialysis-related parameters.

Conditions

Interventions

TypeNameDescription
DEVICEDiffuse Optical SpectroscopyDiffuse Optical Spectroscopy measurements will be compared to a variety of laboratory parameters routinely measured in Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease

Timeline

Start date
2008-08-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2008-11-19
Last updated
2022-10-20

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00793806. Inclusion in this directory is not an endorsement.